Yen Shen Lu, MD

Dr. Lu is currently a Clinical Professor of Medicine at the National Taiwan University College of Medicine, as well as Division Chief of Medical Oncology at Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. Dr Lu graduated from Chinese Medical College, Taichung, in 1992 and obtained his PhD from the National Taiwan University, Taipei, Taiwan, in 2006. He has extensive experience as a clinical trial initiator, protocol writer, clinical trial steering committee member/chair, and as a principal investigator or co-principal investigator for more than 70 clinical trials, with particular focus on targeted agents in metastatic breast cancer. He has been an invited speaker at several international conferences, such as the Oncology Lead Summit, ESMO Asia, and Global Breast Cancer Conference, and has received the Scholar in Training Award at the 92nd Annual Meeting of the American Association Cancer Research in 2001, and Chien-Tien Hsu's Outstanding Cancer Research Award 2019. Additionally, he led a series of studies focusing on young female breast cancer in Asia, regarding to the epidemiology, biology, and genetic differences from that of Western country. He is the author and co-author of more than 90 articles in peer-reviewed international journals, such as Lancet Oncology, Clinical Cancer Research, Journal of National Cancer Institute, and Journal of Clinical Oncology.